Skip to main content
Equibles
ARDX logo

ARDX · Ardelyx, Inc.

Track ARDX — free

Use ARDX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.78 +0.07 (+1.89%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$933.21M
Shares
249.19M

ARDX metrics

68 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.78
Market cap
$933.21M

Price action

19 metrics
Price change (1W)
-0.8%
Price change (30D)
-5.5%
Price change (3M)
-32.0%
Price change (6M)
-38.9%
Price change (YTD)
-35.2%
Price change (1Y)
-42.5%
Trailing year
Price change (5Y)
+162.5%
52-week high
$7.99
52-week low
$3.71
Change from 52-week high
-52.7%
Change from 52-week low
+1.9%
Annualized volatility
61.6%
Beta
0.8
RSI (14D)
32.3
Price vs SMA 50
-18.1%
Price vs SMA 200
-35.4%
Avg volume (3M)
4.23M
Relative volume
0.7
Average dollar volume
$20.39M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
249.19M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.1×
reciprocal yield 48.3%
P / book
6.3
reciprocal yield 16.0%
FCF yield
-1.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
6.0×
reciprocal yield 16.6%
EV / revenue historical average (5Y)
9.7×
reciprocal yield 10.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
-7.9%
Trailing 12 months
Net margin
-12.4%
Gross profit (TTM)
$2.52M
Operating profit (TTM)
−$35.45M
Net income (TTM)
−$55.70M
Trailing 12 months
Diluted EPS (TTM)
$-0.23
FCF margin
-4.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-51.80

Growth

11 metrics
Revenue growth YoY
+23.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$450.89M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.4%
Year over year · more shares
Revenue CAGR (3Y)
+98.4%
Revenue CAGR (5Y)
+121.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-37.4%
Return on assets
-9.7%
Debt / equity
—
Current ratio
3.3
EBITDA (TTM)
−$32.11M
Free cash flow (TTM)
−$17.92M
Quick ratio
2.3
Interest coverage
-1.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$97.19M
Total assets
$575.89M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.32M
Capital expenditures (TTM)
$599,000
R&D (TTM)
$87.21M
SG&A (TTM)
$373.73M
Stock compensation (TTM)
$54.66M
R&D / revenue
19.3%
Stock compensation / revenue
12.1%

Ownership (13F)

3 metrics
13F filers
252
13F filer change QoQ
+9
Institutional ownership
72.2%

Short interest

3 metrics
Short interest
9.0%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.42M
Insider-sentiment score
23 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1437402 CUSIP 039697107 13F (30d) 183 filings 180 filers Visit website Investor relations